Recent Advances in Cancer Stem Cell

Cancer stem cells are one of the causes for the relapse of cancer cells and metastasis. They have drug confrontation in contradiction of most chemotherapeutic agents. Cancer stem cells are also liable for tumor cell heterogeneity and cause negligible residual disease. In order to attain whole deterioration of tumors, cscs have to be targeted. Current developments in immunotherapies have shown promising outcomes in preserving cancer, which are also relevant to target Cancer stem cells. Cscs express immune indicators and display precise immune appearances in numerous cancers, which can be used in immunotherapies to mark cscs in the tumor microenvironment. Lately, numerous policies have been used to target cscs. Adaptive T-cells, dendritic cell (DC)-based vaccines, oncotic viruses, immune checkpoint inhibitors, and combination therapies are now being used to target cscs.

 

 

 

 

 

<p justify;"="">

    Related Conference of Recent Advances in Cancer Stem Cell

    December 08-09, 2025

    5th International Conference on Analytical Chemistry

    Rome, Italy
    December 11-12, 2025

    4th World Congress on Plasma Chemistry and Plasma Processing

    Amsterdam, Netherlands
    December 17-18, 2025

    13th International Conference on Catalysis and Chemical Engineering

    Aix-en-Provence, France
    January 22-23, 2026

    26th World Congress on Medicinal Chemistry and Drug Design

    Bangkok, Thailand
    February 25-26, 2026

    16th International Conference on Chemistry Meeting

    Paris, France
    February 26-27, 2026

    29th World Congress on Materials Chemistry

    Paris, France
    June 17-18, 2026

    15th World Congress on Chromatography

    Paris, France
    September 21-22, 2026

    16th International Chemistry Congress

    Barcelona, Spain

    Recent Advances in Cancer Stem Cell Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in